Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin

NCT02677701 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

NCT NCT02677701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02677701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
Lead sponsor
Seattle Children's Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 21, 2016
Completion date
February 13, 2020
Enrollment
119 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis